NKTR
NKTR
US6402683063
Nektar Therapeutics
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 55.232.000 98.427.000
43.9%
Cost of Revenue -- 30.686.000
--
Gross Profit 55.232.000 67.741.000
18.5%
186.003.000 197.659.000
5.9%
Operating Income -130.771.000 -129.918.000
0.7%
Pretax Income -155.487.000 -119.200.000
30.4%
Net Income Common Stockholders -164.076.000 -118.961.000
37.9%
-- --
--
-- --
--
ende